Daniel C. Ihde
Uniformed Services University of the Health Sciences · 156 works · 12,196 citations · h-index 56
Top works
- A Meta-Analysis of Thoracic Radiotherapy for Small-Cell Lung Cancer
- Chemotherapy of Lung Cancer
- Residual abdominal masses in aggressive non-Hodgkin's lymphoma after combination chemotherapy: significance and management.
- Advances in small cell bronchogenic carcinoma.
- CNS metastases in small cell bronchogenic carcinoma.Increasing frequency and changing pattern with lengthening survival
- Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial.
- Combined modality therapy with electron-beam irradiation and systemic chemotherapy for cutaneous T-cell lymphomas.
- Small cell lung cancer 1973–1983: Early progress and recent obstacles
- MDR1 Gene Expression in Lung Cancer
- Clinical manifestations of hepatoma
- SERUM NEURON-SPECIFIC ENOLASE: A MARKER FOR DISEASE EXTENT AND RESPONSE TO THERAPY OF SMALL-CELL LUNG CANCER
- Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma.
- A Randomized Trial Comparing Combination Electron-Beam Radiation and Chemotherapy with Topical Therapy in the Initial Treatment of Mycosis Fungoides
- Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure.
- The treatment of indolent lymphomas: watchful waiting v aggressive combined modality treatment.
- NCI-navy medical oncology branch cell line data base
- Clinical spectrum of infection due to Bacillus species
- myc family oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and course.
- The clinical behavior of „mixed” small cell/large cell bronchogenic carcinoma compared to „pure” small cell subtypes
- Therapeutic trials with VP-16-213 and VM-26: active agents in small cell lung cancer, non-Hodgkin's lymphomas, and other malignancies.